Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2601
Planet Labs
PL
$6.37B
| $2.65M | ﹤0.01% |
434,410
+169,827
| +64% | +$694K |
2022 Q2
12 quarters
|
|
2602
PUT
Airbnb
ABNB
$95.8B
| $2.65M | ﹤0.01% |
20,000
-137,900
| -87% | -$17.5M |
2024 Q3
3 quarters
|
|
2603
Collegium Pharmaceutical
COLL
$717M
| $2.64M | ﹤0.01% |
89,434
+15,731
| +21% | +$449K |
2015 Q2
40 quarters
|
|
2604
UiPath
PATH
$6.84B
| $2.64M | ﹤0.01% |
206,261
-4,999
| -2% | -$60K |
2022 Q1
13 quarters
|
|
2605
Diebold Nixdorf
DBD
$2.16B
| $2.64M | ﹤0.01% |
47,634
+19,013
| +66% | +$892K |
2023 Q4
6 quarters
|
|
2606
PUT
Match Group
MTCH
$9.26B
| $2.64M | ﹤0.01% |
85,400
| – | – |
2025 Q1
1 quarter
|
|
2607
CALL
Xerox
XRX
$397M
| $2.63M | ﹤0.01% |
+500,000
| New | +$2.44M |
2025 Q2
0 quarters
|
|
2608
Ziff Davis
ZD
$1.89B
| $2.63M | ﹤0.01% |
87,030
+29,985
| +53% | +$964K |
2013 Q2
48 quarters
|
|
|
MRC
2609
DELISTED
MRC Global
MRC
| $2.63M | ﹤0.01% |
191,997
-250,652
| -57% | -$3.02M |
2013 Q2
48 quarters
|
|
2610
Dentsply Sirona
XRAY
$1.73B
| $2.63M | ﹤0.01% |
165,409
+32,308
| +24% | +$483K |
2013 Q2
48 quarters
|
|
2611
Lionsgate Studios
LION
$3.32B
| $2.63M | ﹤0.01% |
452,095
+409,675
| +966% | +$2.74M |
2024 Q4
2 quarters
|
|
2612
Evolv Technologies
EVLV
$828M
| $2.62M | ﹤0.01% |
420,613
+253,861
| +152% | +$1.17M |
2022 Q1
13 quarters
|
|
2613
Marcus & Millichap
MMI
$1.08B
| $2.62M | ﹤0.01% |
85,401
+28,909
| +51% | +$877K |
2016 Q3
35 quarters
|
|
2614
Anavex Life Sciences
AVXL
$169M
| $2.62M | ﹤0.01% |
284,259
+135,584
| +91% | +$1.16M |
2021 Q4
14 quarters
|
|
2615
CALL
Aurora
AUR
$11.4B
| $2.62M | ﹤0.01% |
+500,000
| New | +$3.14M |
2025 Q2
0 quarters
|
|
|
2616
PUT
Aurora
AUR
$11.4B
| $2.62M | ﹤0.01% |
+500,000
| New | +$3.14M |
2025 Q2
0 quarters
|
|
2617
German American Bancorp
GABC
$1.86B
| $2.62M | ﹤0.01% |
68,002
+31,108
| +84% | +$1.17M |
2016 Q1
37 quarters
|
|
2618
Credit Acceptance
CACC
$5.48B
| $2.62M | ﹤0.01% |
5,140
+1,789
| +53% | +$879K |
2016 Q2
36 quarters
|
|
2619
Kforce
KFRC
$947M
| $2.6M | ﹤0.01% |
63,284
+10,069
| +19% | +$422K |
2016 Q2
36 quarters
|
|
2620
TriCo Bancshares
TCBK
$1.68B
| $2.6M | ﹤0.01% |
64,158
+18,281
| +40% | +$718K |
2016 Q1
37 quarters
|
|
|
AAT
2621
American Assets Trust
AAT
$1.32B
| $2.6M | ﹤0.01% |
131,522
+39,240
| +43% | +$763K |
2013 Q2
48 quarters
|
|
2622
VF Corp
VFC
$5.63B
| $2.59M | ﹤0.01% |
220,712
-273,672
| -55% | -$3.39M |
2013 Q2
48 quarters
|
|
2623
Bruker
BRKR
$9.64B
| $2.59M | ﹤0.01% |
62,867
-37,996
| -38% | -$1.47M |
2013 Q2
48 quarters
|
|
2624
DHT Holdings
DHT
$3.82B
| $2.59M | ﹤0.01% |
239,281
+80,254
| +50% | +$885K |
2016 Q2
36 quarters
|
|
2625
Kirby Corp
KEX
$7.28B
| $2.59M | ﹤0.01% |
22,798
+2,230
| +11% | +$234K |
2013 Q2
48 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.